Literature DB >> 70750

Ventricular premature beats and mortality after myocardial infarction.

W Ruberman, E Weinblatt, J D Goldberg, C W Frank, S Shapiro.   

Abstract

To assess the role of ventricular premature beats in influencing mortality of coronary patients, 1739 men with prior myocardial infarction were monitored for ectopic activity for one hour at a standard base-line examination, and followed for mortality for periods up to four years (average, 24.4 months). Analyses of survival taking into account other important prognostic variables establish that the presence of complex premature beats (R on T, runs of 2 or more, multiform or bigeminal premature beats) in the monitoring hour is associated with a risk of sudden coronary death three times that of the men free of complex ventricular premature beats. The corresponding risk of death from any cause is twice that of men without such complex beats in the hour. These arrhythmias make an independent contribution to increased risk of death that persists over the length of this observation period.

Entities:  

Mesh:

Year:  1977        PMID: 70750     DOI: 10.1056/NEJM197710062971404

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  43 in total

1.  The heart of the matter of opinion and evidence: the value of evidence-based medicine.

Authors:  Daniel Masvidal; Carl J Lavie
Journal:  Ochsner J       Date:  2012

Review 2.  Antiarrhythmic therapies for the prevention of sudden cardiac death.

Authors:  F A McAlister; K K Teo
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

Review 3.  Risk-benefit assessment of antiarrhythmic drugs. An epidemiological perspective.

Authors:  L Friedman; E Schron; S Yusuf
Journal:  Drug Saf       Date:  1991 Sep-Oct       Impact factor: 5.606

4.  Frequency of extrasystoles in healthy male employees.

Authors:  K Orth-Gomér; C Hogstedt; L Bodin; B Söderholm
Journal:  Br Heart J       Date:  1986-03

Review 5.  Programmed stimulation of the ventricles--back to the future.

Authors:  A E Buxton
Journal:  J Interv Card Electrophysiol       Date:  1997-12       Impact factor: 1.900

Review 6.  Adverse effects of class I antiarrhythmic drugs.

Authors:  J Caron; C Libersa
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

7.  Segmental wall motion abnormalities alter vulnerability to ventricular ectopic beats associated with acute increases in aortic pressure in patients with underlying coronary artery disease.

Authors:  K Siogas; S Pappas; G Graekas; J Goudevenos; G Liapi; D A Sideris
Journal:  Heart       Date:  1998-03       Impact factor: 5.994

8.  Treatment of malignant ventricular arrhythmias with the automatic implantable cardioverter defibrillator.

Authors:  A D Slater; I Singer; C S Stavens; C Zee-Cheng; B L Ganzel; J Kupersmith; C Mavroudis; L A Gray
Journal:  Ann Surg       Date:  1989-05       Impact factor: 12.969

9.  BW A256C, a chemically novel class 1 antiarrhythmic agent. A comparison of in vitro and in vivo activity with other class 1 antiarrhythmic agents.

Authors:  G Allan; S Donoghue; M J Follenfant; D A Sawyer
Journal:  Br J Pharmacol       Date:  1986-06       Impact factor: 8.739

Review 10.  The management of ventricular arrhythmias in older patients after CAST.

Authors:  W S Aronow
Journal:  Drugs Aging       Date:  1995-02       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.